생어 시퀀스 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 연간 평균 성장률(CAGR) 16.9%로 성장할 전망이며, 61억 7,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 임상 유전체학 통합 증가, 농업 유전체학 확대, 약제 안전성 및 약리 유전체학 증가, 출생 전 및 신생아 스크리닝 증가, 환경 DNA 분석의 증가에 기인할 것으로 보입니다. 예측 기간 주요 동향에는 기술의 진보, 차세대 시퀀스 수요 확대, 임상 진단에 대한 용도 확대, 유전체학 연구에 대한 투자 증가, 개별화 의료에서 이용 확대 등이 있습니다.
유전성 질환 증가는 향후 수년간 생어 시퀀스 시장의 성장을 견인할 것으로 예상됩니다. 유전성 질환(유전성 장애)이란 유전정보를 전달하는 유전물질인 개인 DNA의 이상 및 변이에 의해 발생하는 병세입니다. 생어 시퀀스는 특정 유전자나 DNA 영역의 뉴클레오타이드(DNA의 구성 요소)의 정확한 순서를 결정함으로써 이러한 질환을 진단하는 데 사용되는 방법입니다. 예를 들면, 2024년 8월, 영국의 공적 의료기관인 내셔널 헬스 케어 서비스(National Health Service)는, 영국에서 약 2,300명이 사라세미아에 이환하고 있으며, 그 중 약 800명이 정기적인 수혈에 의지하는 중증형이라고 보고했습니다. 이처럼 유전성 질환의 증가가 생어 시퀀스 시장 성장에 박차를 가하고 있습니다.
생어 시퀀스 시장의 주요 기업은 영국 북부에서 신속한 생어 시퀀스 서비스를 제공하기 위해 유전체 연구소의 확대에 주력하고 있습니다. 유전체 연구소는 진단, 연구, 개별화 의료 등의 목적으로 유전자 및 유전체의 구조, 기능, 유전을 연구하는 것을 목적으로 한, 유전자 검사나 분석을 실시하기 위한 전문 시설입니다. 예를 들면, 2023년 6월, 영국을 거점으로 하는 유전체 서비스의 프로바이더인 소스 제노믹스사는, 유전체 연구소의 영국 북부로의 확장을 발표했습니다. 이러한 지리적 확장은 영국 전역에서 유전체 서비스에 대한 공평한 접근을 제공하기 위한 중요한 단계이며, 전국의 연구기관이 보다 신속한 납기로 고품질 생어 시퀀스 서비스의 혜택을 받을 수 있게 되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 생어 시퀀스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 생어 시퀀스 Market: 성장률 분석
- 세계의 생어 시퀀스 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 생어 시퀀스 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 생어 시퀀스 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 생어 시퀀스 시장 : 시퀀스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 샷건 시퀀스
- 표적 유전자 시퀀스
- 기타 시퀀스
- 세계의 생어 시퀀스 시장 : 연구실별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 습식 랩
- 건식 랩
- 세계의 생어 시퀀스 시장 : 조사별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 사내
- 아웃소싱
- 세계의 생어 시퀀스 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 진단
- 바이오마커 및 암
- 생식에 관한 건강
- 맞춤형 의료
- 법의학
- 기타 용도
- 세계의 생어 시퀀스 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 아카데믹
- 정부연구기관
- 제약회사
- 바이오테크놀러지 기업
- 병원
- 클리닉
- 세계의 생어 시퀀스 시장 : 샷건 시퀀스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 전체 유전체 샷건 시퀀스
- 메타 유전체 샷건 시퀀스
- 세계의 생어 시퀀스 시장 : 표적 유전자 서열별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 앰플리콘 시퀀스
- 엑솜 시퀀스
- 세계의 생어 시퀀스 시장 : 기타 시퀀스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 중첩 PCR 시퀀스
- 시퀀스 바이 신세시스(SBS)
제7장 지역별 및 국가별 분석
- 세계의 생어 시퀀스 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 생어 시퀀스 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 생어 시퀀스 시장 : 경쟁 구도
- 생어 시퀀스 시장 : 기업 프로파일
- Hoffmann-La Roche 개요, 제품 및 서비스, 전략 및 재무 분석
- Thermo Fisher Scientific Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck KGaA 개요, 제품 및 서비스, 전략 및 재무 분석
- Eurofins Scientific 개요, 제품 및 서비스, 전략 및 재무 분석
- Illumina Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Beckman Coulter
- PerkinElmer Inc.
- BGI Group
- LGC Limited
- GenScript
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.
- Macrogen Inc.
- GENEWIZ Inc.
- Quintara Biosciences
- CeMIA SA
- Source BioScience
- Microsynth AG
- Fasteris SA
- GenHunter Corporation
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 생어 시퀀스 시장 : 새로운 기회를 제공하는 국가(2029년)
- 생어 시퀀스 시장 : 새로운 기회를 제공하는 부문(2029년)
- 생어 시퀀스 시장 : 성장 전략(2029년)
제36장 부록
AJY
Sanger sequencing, also known as chain termination sequencing, is a technique utilized to determine the nucleotide sequence of DNA. It finds application in smaller-scale projects and validating the results of deep sequencing, producing DNA sequence reads exceeding 500 nucleotides while maintaining high accuracy levels.
Sanger sequencing encompasses several types, including shotgun sequencing, targeted gene sequencing, and others. In shotgun sequencing, random fragments of a lengthy DNA molecule are sequenced in parallel and then pieced together using their overlapping segments. Laboratories employing Sanger sequencing methods can be categorized as wet labs or dry labs, while research endeavors can be conducted in-house or outsourced. These techniques are employed across various applications such as diagnostics, biomarkers, cancer research, reproductive health, personalized medicine, forensics, among others. Moreover, Sanger sequencing serves a diverse range of end-users including academic institutions, government research institutes, pharmaceutical companies, biotechnology firms, hospitals, and clinics.
The sanger sequencing market research report is one of a series of new reports from The Business Research Company that provides sanger sequencing market statistics, including sanger sequencing industry global market size, regional shares, competitors with a sanger sequencing market share, detailed sanger sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the sanger sequencing industry. This sanger sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.75 billion in 2024 to $3.3 billion in 2025 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to increased research demand, increasing medical diagnostics, increased pharmaceutical development, increased agricultural applications, increased forensic analysis, increased biomarker discovery, increased genetic evolution studies.
The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $6.17 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to increasing clinical genomics integration, expanded agricultural genomics, increasing drug safety and pharmacogenomics, increasing prenatal and newborn screening, increasing environmental DNA analysis. Major trends in the forecast period include technological advancements, growing demand for next-generation sequencing, increasing applications in clinical diagnostics, rising investments in genomics research, expanding use in personalized medicine.
The increase in genetic illnesses is expected to drive the growth of the Sanger sequencing market in the coming years. Genetic illnesses, or genetic disorders, are medical conditions caused by abnormalities or mutations in an individual's DNA, the hereditary material that carries genetic information. Sanger sequencing is a method used to diagnose these disorders by determining the precise order of nucleotides (the building blocks of DNA) in a specific gene or DNA region. For example, in August 2024, the National Health Service, a UK-based publicly funded healthcare organization, reported that around 2,300 people in the UK are living with thalassemia, with approximately 800 individuals affected by the severe form of the condition who rely on regular blood transfusions. Thus, the rise in genetic illnesses is fueling the growth of the Sanger sequencing market.
Leading companies in the Sanger sequencing market are focusing on expanding genomic laboratories to offer rapid Sanger sequencing services in the northern UK. Genomic laboratories are specialized facilities for conducting genetic testing and analysis, aimed at studying the structure, function, and inheritance of genes and genomes for purposes such as diagnosis, research, and personalized medicine. In June 2023, for instance, Source Genomics, a UK-based provider of genomic services, announced the expansion of their genomic laboratory to the north of the UK, which will increase their capacity for Sanger sequencing services and reduce data turnaround times. This geographic expansion represents a significant step in providing equitable access to genomic services across the UK, enabling research organizations nationwide to benefit from high-quality Sanger sequencing services with faster turnaround times.
In January 2023, Qiagen, a German company specializing in sample and assay technologies, acquired Verogen for $150 million. This strategic move enables Qiagen to optimize its renowned sample extraction and library preparation automation capabilities, thereby bolstering the channel reach and market presence of both companies in support of the forensic market. Verogen, based in the United States, is a leading provider of Sanger sequencing solutions tailored for human identification and forensic laboratories.
Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies
North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sanger sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sanger sequencing market includes revenues earned by entities by providing DNA synthesis, and targeted synthesis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sanger Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sanger sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sanger sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sanger sequencing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Sequencing: Shotgun Sequencing; Targeted Gene Sequencing; Other Sequencing
- 2) By Laboratory: Wet Labs; Dry Labs
- 3) By Research: In-House; Outsourced
- 4) By Application: Diagnostics; Biomarkers and Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
- 5) By End User: Academic; Government Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Hospitals; Clinics
- Subsegments:
- 1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing; Metagenomic Shotgun Sequencing
- 2) By Targeted Gene Sequencing: Amplicon Sequencing; Exome Sequencing
- 3) By Other Sequencing: Nested PCR Sequencing; Sequencing By Synthesis (SBS)
- Companies Mentioned: Hoffmann-La Roche; Thermo Fisher Scientific Inc.; Merck KGaA; Eurofins Scientific; Illumina Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sanger Sequencing Market Characteristics
3. Sanger Sequencing Market Trends And Strategies
4. Sanger Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Sanger Sequencing Growth Analysis And Strategic Analysis Framework
- 5.1. Global Sanger Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Sanger Sequencing Market Growth Rate Analysis
- 5.4. Global Sanger Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Sanger Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Sanger Sequencing Total Addressable Market (TAM)
6. Sanger Sequencing Market Segmentation
- 6.1. Global Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Shotgun Sequencing
- Targeted Gene Sequencing
- Other Sequencing
- 6.2. Global Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Wet Labs
- Dry Labs
- 6.3. Global Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- In-House
- Outsourced
- 6.4. Global Sanger Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Forensics
- Other Applications
- 6.5. Global Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Academic
- Government Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals
- Clinics
- 6.6. Global Sanger Sequencing Market, Sub-Segmentation Of Shotgun Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Whole Genome Shotgun Sequencing
- Metagenomic Shotgun Sequencing
- 6.7. Global Sanger Sequencing Market, Sub-Segmentation Of Targeted Gene Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Amplicon Sequencing
- Exome Sequencing
- 6.8. Global Sanger Sequencing Market, Sub-Segmentation Of Other Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nested PCR Sequencing
- Sequencing By Synthesis (SBS)
7. Sanger Sequencing Market Regional And Country Analysis
- 7.1. Global Sanger Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Sanger Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Sanger Sequencing Market
- 8.1. Asia-Pacific Sanger Sequencing Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Sanger Sequencing Market
- 9.1. China Sanger Sequencing Market Overview
- 9.2. China Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Sanger Sequencing Market
- 10.1. India Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Sanger Sequencing Market
- 11.1. Japan Sanger Sequencing Market Overview
- 11.2. Japan Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Sanger Sequencing Market
- 12.1. Australia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Sanger Sequencing Market
- 13.1. Indonesia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Sanger Sequencing Market
- 14.1. South Korea Sanger Sequencing Market Overview
- 14.2. South Korea Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Sanger Sequencing Market
- 15.1. Western Europe Sanger Sequencing Market Overview
- 15.2. Western Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Sanger Sequencing Market
- 16.1. UK Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Sanger Sequencing Market
- 17.1. Germany Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Sanger Sequencing Market
- 18.1. France Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Sanger Sequencing Market
- 19.1. Italy Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Sanger Sequencing Market
- 20.1. Spain Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Sanger Sequencing Market
- 21.1. Eastern Europe Sanger Sequencing Market Overview
- 21.2. Eastern Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Sanger Sequencing Market
- 22.1. Russia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Sanger Sequencing Market
- 23.1. North America Sanger Sequencing Market Overview
- 23.2. North America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Sanger Sequencing Market
- 24.1. USA Sanger Sequencing Market Overview
- 24.2. USA Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Sanger Sequencing Market
- 25.1. Canada Sanger Sequencing Market Overview
- 25.2. Canada Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Sanger Sequencing Market
- 26.1. South America Sanger Sequencing Market Overview
- 26.2. South America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Sanger Sequencing Market
- 27.1. Brazil Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Sanger Sequencing Market
- 28.1. Middle East Sanger Sequencing Market Overview
- 28.2. Middle East Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Sanger Sequencing Market
- 29.1. Africa Sanger Sequencing Market Overview
- 29.2. Africa Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Sanger Sequencing Market Competitive Landscape And Company Profiles
- 30.1. Sanger Sequencing Market Competitive Landscape
- 30.2. Sanger Sequencing Market Company Profiles
- 30.2.1. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Sanger Sequencing Market Other Major And Innovative Companies
- 31.1. Beckman Coulter
- 31.2. PerkinElmer Inc.
- 31.3. BGI Group
- 31.4. LGC Limited
- 31.5. GenScript
- 31.6. Oxford Nanopore Technologies
- 31.7. Pacific Biosciences of California Inc.
- 31.8. Macrogen Inc.
- 31.9. GENEWIZ Inc.
- 31.10. Quintara Biosciences
- 31.11. CeMIA SA
- 31.12. Source BioScience
- 31.13. Microsynth AG
- 31.14. Fasteris SA
- 31.15. GenHunter Corporation
32. Global Sanger Sequencing Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Sanger Sequencing Market
34. Recent Developments In The Sanger Sequencing Market
35. Sanger Sequencing Market High Potential Countries, Segments and Strategies
- 35.1 Sanger Sequencing Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Sanger Sequencing Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Sanger Sequencing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
